NY S02926 | 2023-2024 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2024-01-03 - REFERRED TO INSURANCE
Pending: Senate Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2024-01-03 - REFERRED TO INSURANCE
Pending: Senate Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Provides that every policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or diagnostic X-rays shall provide coverage for testing of familial dysautonomia, Canavan's disease and Tay-Sachs; provides that in order to maintain the confidentiality of persons tested, receipt of acknowledgement from the testing facility shall be deemed sufficient evidence of testing.
Title
Provides that every policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or diagnostic X-rays shall provide coverage for testing of familial dysautonomia, Canavan's disease and Tay-Sachs; provides that in order to maintain the confidentiality of persons tested, receipt of acknowledgement from the testing facility shall be deemed sufficient evidence of testing.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-01-03 | Senate | REFERRED TO INSURANCE |
| 2023-01-25 | Senate | REFERRED TO INSURANCE |
Same As/Similar To
A01792 (Same As) 2024-01-03 - referred to insurance
